^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    VicOryx (P16_37-63)

    i
    Other names: P16_37-63, p16INK4a peptide vaccine, human papillomavirus vaccine, p16INK4a-37-63
    Associations
    News
    Trials
    Company:
    Oryx
    Drug class:
    CDKN2A inhibitor
    Associations
    News
    Trials